Worldwide Specialty PACS Industry to 2029 - Featuring IBM, McKesson, Agfa Healthcare and Sectra Among Others - ResearchAndMarkets.com

03 Jan 2023
www.businesswire.com
DUBLIN--(BUSINESS WIRE)--The "Specialty PACS Market Analysis by Type, by Component, by Deployment Model, End user and by Region - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.
'Specialty PACS Market Analysis by Type, by Component, by Deployment Model, End user and by Region - Global Forecast to 2029'
The specialty PACS market size is estimated to be USD 2.9 billion in 2021 and is expected to witness a CAGR of 8.62% during the forecast period 2022-2029.
The growing geriatric population and consequent increase in the incidence of various diseases, benefits associated with specialty PACS, government efforts boost the acceptance of healthcare IT solutions, rising investments in medical imaging, increased adoption of medical imaging IT solutions, and expanding use of imaging equipment are some of the key drivers for the market growth. However, budgeting restrictions are expected to restrain the market growth.
Companies Mentioned
Agfa Healthcare (Belgium)
Carestream Health (a part of Onex Corporation) (Canada)
Philips Healthcare (Netherlands)
Sectra AB (Sweden)
Novarad (US)
INFINITT North America (US)
Sonomed Escalon (US)
Canon USA Inc. (US) (a subsidiary of Canon Inc.)
Visbion (UK)
Market Segmentation:
By Type (Revenue, USD Billion)
Radiology PACS
Ophthalmology PACS
Endoscopy PACS
Women's Health PACS
Oncology PACS
Orthopaedics PACS
Pathology PACS
Dermatology PACS
Neurology PACS
Others
By Component (Revenue, USD Billion)
Software
Services
Hardware
By Deployment Model (Revenue, USD Billion)
Cloud-based
On-premise
By End user (Revenue, USD Billion)
Ambulatory Surgery Centres
Diagnostic Imaging Centres
Hospitals
Others
By Region (Revenue, USD Billion)
North America
U.S
Canada
Europe
Germany
France
UK
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Rest of LATAM
Middle East & Africa
South Africa
GCC
Rest of MEA
For more information about this report visit https://www.researchandmarkets.com/r/a1cimr
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-
Targets
-
Drugs
-
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.